Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4068 results

Sort By:

Assessment of DOT Spectacles in Chinese Children Extension

Study ID: NCT07008001
Start Date: 2025-06-30
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

175

Intervention / Treatment

Novel spectacle lens design

Sponsor

SightGlass Vision, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Implementation Study to Describe and Compare Retention Rate and Adherence to Adjuvant Therapy With Ribociclib With and Without Usage of Mobile Application in Patients With HR+ HER2-negative Stage II and III Breast Cancer in Real-world Practice

Study ID: NCT06905301
Start Date: 2025-07-31
End Date: 2029-07-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

240

Intervention / Treatment

Ribociclib

Letrozole

Anastrozole

Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

BZLF1 Peptide Vaccine (OSU-2131) with QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants

Study ID: NCT06741072
Start Date: 2025-07-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

55

Intervention / Treatment

Biospecimen Collection

Dulbecco''s Phosphate-Buffered Saline

Peptide Vaccine

QS21

Sponsor

Ohio State University Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients with AML

Study ID: NCT05662904
Start Date: 2028-01
End Date: 2030-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

12

Intervention / Treatment

Donor-derived CD34+ HSC with CRISPR/Cas9-mediated CD33 deletion

Gemtuzumab ozogamicin

Sponsor

German Cancer Research Center

Source: clinicaltrials.gov

Share:
Add to list

Clinical Efficacy of Exoskeleton Assistance for Individuals Post-Stroke

Study ID: NCT06064604
Start Date: 2027-01-01
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Control

Hip Exoskeleton

Ankle Exoskeleton

Sponsor

Georgia Institute of Technology

Source: clinicaltrials.gov

Share:
Add to list

HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT

Study ID: NCT06731504
Start Date: 2025-07
End Date: 2028-07
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

10

Intervention / Treatment

Abatacept

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

Vagus Nerve Stimulation to the Ear to Improve Symptoms in Post-COVID-19 and ME/CFS

Study ID: NCT06968104
Start Date: 2025-07
End Date: 2026-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

48

Intervention / Treatment

transcutaneous vagus nerve stimulation

transcutaneous vagus nerve stimulation

Sponsor

University of Luxembourg

Source: clinicaltrials.gov

Share:
Add to list

Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors

Study ID: NCT06834204
Start Date: 2025-07-01
End Date: 2029-04-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

266

Intervention / Treatment

PC2: Primary Care Connect

Sponsor

Rutgers, The State University of New Jersey

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042

Study ID: NCT06916169
Start Date: 2025-08
End Date: 2025-09
Study Type

Interventional

Study Phase

Phase1

No. of Participants

70

Intervention / Treatment

AG2304

AG23041 and AG23042

Sponsor

Ahn-Gook Pharmaceuticals Co.,Ltd

Source: clinicaltrials.gov

Share:
Add to list

Development and Testing of Nutritional Algorithms (NACHO)

Study ID: NCT05825469
Start Date: 2025-07-01
End Date: 2026-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

130

Intervention / Treatment

Nutrition Algorithm

Sponsor

Dana-Farber Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list